MAbxience | WebDisclosure

BRIEF

published on 10/01/2026 at 07:10, 10 days 15 hours ago

Fresenius Acquires Full Ownership of mAbxience

Acquisition Biosimilars Biopharma Fresenius MAbxience
BRIEF

published on 10/01/2026 at 07:10, 10 days 15 hours ago

Fresenius acquiert la pleine propriété de mAbxience

Acquisition Biopharma Biosimilaires Fresenius MAbxience
PRESS RELEASE

published on 10/01/2026 at 07:05, 10 days 15 hours ago

Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion
Fresenius completes acquisition of mAbxience, enhancing biosimilars platform to support future innovation and patient access. Full ownership strengthens quality and supply resilience

Acquisition Innovation Biosimilars Fresenius MAbxience
BRIEF

published on 09/18/2026 at 12:40, 23 days 9 hours ago

MAbxience and Sandoz Join Forces to Enhance Global Access to Biosimilars

Biosimilar Global Healthcare Sandoz Hemophilia A MAbxience
BRIEF

published on 09/18/2026 at 12:40, 23 days 9 hours ago

MAbxience et Sandoz unissent leurs forces pour améliorer l'accès mondial aux biosimilaires

Santé Mondiale Biosimilaire Sandoz Hémophilie A MAbxience
PRESS RELEASE

published on 09/18/2026 at 12:35, 23 days 9 hours ago

mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
mAbxience and Sandoz sign a collaboration agreement to advance biosimilar access worldwide, combining development and commercial expertise to broaden patient access to high-quality biologic medicines

Collaboration Agreement Sandoz MAbxience Emicizumab Biosimilar Access
BRIEF

published on 12/22/2025 at 22:10, 9 months 20 days ago

FDA Approves mAbxience and Amneal's Denosumab Biosimilars

FDA Approval Amneal Pharmaceuticals Denosumab Biosimilars MAbxience Affordable Biologics
BRIEF

published on 12/22/2025 at 22:10, 9 months 20 days ago

La FDA approuve les biosimilaires de dénosumab de mAbxience et d'Amneal

Approbation De La FDA Amneal Pharmaceuticals Biosimilaires Du Dénosumab MAbxience Produits Biologiques Abordables
PRESS RELEASE

published on 12/22/2025 at 22:05, 9 months 20 days ago

mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
mAbxience and Amneal announced FDA approval of denosumab biosimilars referencing Prolia and XGEVA, expanding affordable biologic access in the US

FDA Approval Denosumab Biosimilars MAbxience Amneal Prolia XGEVA
BRIEF

published on 12/04/2025 at 09:10, 10 months 7 days ago

MAbxience and HP Collaborate on AI in Biomanufacturing

Artificial Intelligence Biosimilars Biomanufacturing MAbxience HP Inc.

Published on 10/10/2026 at 04:45, 1 day 17 hours ago

Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 1 day 20 hours ago

BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 1 day 20 hours ago

Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 1 day 23 hours ago

Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 2 days ago

Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call

View all ACCESSWIRE

Published on 10/10/2026 at 16:35, 1 day 5 hours ago

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 1 day 5 hours ago

ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 1 day 12 hours ago

ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 2 days 1 hour ago

Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 2 days 1 hour ago

EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected

View all EQS

Published on 10/09/2026 at 19:27, 2 days 2 hours ago

Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 2 days 2 hours ago

Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 18:01, 2 days 4 hours ago

Titre de mon communiqué
Published on 10/09/2026 at 18:01, 2 days 4 hours ago

Title of my press release
Published on 10/09/2026 at 17:45, 2 days 4 hours ago

Déclaration des droits de vote à fin septembre 2026

View all LES ECHOS COMFI WIRE

News